0000905718-15-000564.txt : 20150701 0000905718-15-000564.hdr.sgml : 20150701 20150701091035 ACCESSION NUMBER: 0000905718-15-000564 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150701 FILED AS OF DATE: 20150701 DATE AS OF CHANGE: 20150701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wright Richard M. CENTRAL INDEX KEY: 0001646423 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 15963234 MAIL ADDRESS: STREET 1: C/O CELLDEX THERAPEUTICS, INC. STREET 2: 53 FRONTAGE ROAD, SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 3 1 wright_form3jun292015.xml OWNERSHIP DOCUMENT X0206 3 2015-07-01 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001646423 Wright Richard M. C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220 HAMPTON NJ 08827 0 1 0 0 Sr. VP & CCO Common stock, par value $0.001 per share 3125 D Employee Stock Option (right to buy) 3.99 2022-06-01 Common Stock 12500 D Employee Stock Option (right to buy) 16.36 2023-07-01 Common Stock 20000 D Employee Stock Option (right to buy) 13.45 2024-06-04 Common Stock 25000 D Employee Stock Option (right to buy) 25.41 2025-06-10 Common Stock 75000 D The option became exercisable as to 25% of the shares on 6/1/2013. This option is currently vested as to 6,250 shares and the remaining shares vest quarterly (in equal amounts) over the subsequent 4 quarters. The option became exercisable as to 25% of the shares on 7/1/2014. This option is currently vested as to 10,000 shares and the remaining shares vest quarterly (in equal amounts) over the subsequent 8 quarters. The option became exercisable as to 25% of the shares on 6/4/2015. This option is currently vested as to 6,250 shares and the remaining shares vest quarterly (in equal amounts) over the subsequent 12 quarters. The option becomes exercisable as to 25% of the shares on 6/10/2016 and the remaining shares vest quarterly (in equal amounts) over the subsequent 12 quarters. Exhibit 24.1 - Power of Attorney /s/ Avery W. Catlin, attorney-in-fact 2015-07-01 EX-24 2 wright_poa.htm EXHIBIT 24.1 POWER OF ATTORNEY

 

 

POWER OF ATTORNEY

 

Known by all those present, that the undersigned hereby constitutes and appoints each of Avery W. Catlin and Anthony S. Marucci as [his/his] true and lawful attorneys-in-fact to:

 

(1) execute for and on behalf of the undersigned Schedules 13D and 13G, Form ID, and Forms 3, 4 and 5 in accordance with Sections 13 and 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

 

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete the execution of any such Schedules 13D or 13G, Form ID and Forms 3, 4, or 5, and the timely filing of such Forms with the United States Securities and Exchange Commission and any other authority; and

 

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, including without limitation the execution and filing of a Form 4 with respect to a transaction which may be reported on a Form 5, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary,and proper to be done in the exercise of any of the rights and powers herein granted, as fully and to all intents and purposes as he might or could do in person, with full power of substitution or resubstitution, hereby ratifying and confirming all that such attorney-in-fact, or his substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned’s responsibilities to comply with Sections 13 and 16 of the Securities Exchange Act of 1934.

  

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 18th day of June, 2015.

 

 

  /s/ Richard M. Wright  
  Signature  
     
     
  Name: Richard M. Wright